[Experimental therapy of poisoning by anticholinesterase medicinal preparations].
D000549:Ambenonium Chloride / Q000506:poisoning; D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000506:poisoning* / Q000627:therapeutic use / Q000633:toxicity; D003864:Depression, Chemical; D004357:Drug Synergism; D005702:Galantamine / Q000506:poisoning; D005730:Ganglionic Blockers / Q000627:therapeutic use; D008297:Male; D008916:Miotics / Q000506:poisoning; D009388:Neostigmine / Q000506:poisoning; D062025:Organophosphate Poisoning; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D010710:Phosphates / Q000506:poisoning; D010830:Physostigmine / Q000506:poisoning; D051381:Rats; D012737:Sex Factors; D013565:Sympatholytics / Q000506:poisoning; D014403:Tubocurarine / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D005730:Ganglionic Blockers; D008916:Miotics; D010276:Parasympatholytics; D010710:Phosphates; D013565:Sympatholytics; D005702:Galantamine; D009388:Neostigmine; D000549:Ambenonium Chloride; D001285:Atropine; D010830:Physostigmine; D014403:Tubocurarine
Eksperimental'naia terapiia otravleniĭ antikholinésteraznymi lekarstvennymi preparatami.